Evidence map›Paper›PMID 22586036›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals.

Shao Chong Zhang, Eric Martin, Mariko Shimada, Sasha Blue Godfrey, Jennifer Fricke, Shirley Locastro, Nicole Y Lai, Paul Liebesny, Jonathan M Carlson, Chanson J Brumme and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. CD8+ TCR Bias and Immunodominance in HIV-1 Infection.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Shao Chong ZhangRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Eric Martin
Mariko Shimada
Sasha Blue Godfrey
Jennifer Fricke
Shirley Locastro
Nicole Y Lai
Paul Liebesny
Jonathan M Carlson
Chanson J Brumme
Oluwatobi Awele Ogbechie
Huabiao Chen
Bruce D Walker
Zabrina L Brumme
Daniel G Kavanagh
Sylvie Le Gall
Harvard University · USRagon Institute of MGH, MIT and Harvard · USSimon Fraser University · CAAIDS Vancouver · CAHoward Hughes Medical Institute · USMicrosoft Research (United Kingdom) · GB

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Recognition of HIV-1 by Innate Immunity Receptors during Primary InfectionP01AI074415 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2008 to 2013
$17.3M
Mechanisms and optimization of epitope presentation by HIV-infectable cell subsetR01AI084753 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LE GALL, SYLVIE · 2009 to 2013
$2.3M
Immune responses against HIV-induced cell-derived neoepitopes and HIV controlR01AI084106 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LE GALL, SYLVIE · 2009 to 2012
$2.1M
Development of needle-free, vectorless, RNA-based vaccines for HIVR21AI083133 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAVANAGH, DANIEL GARRETT · 2009 to 2010
$470k
HLA restriction and TCR affinity in HIVR56AI095088 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAVANAGH, DANIEL GARRETT · 2011 to 2011
$439k
CIHRHoward Hughes Medical InstituteNIAID NIH HHS AI074415-02S1NIAID NIH HHS P01 AI074415NIAID NIH HHS P01 AI074415-01A1NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI084106NIAID NIH HHS R01 AI084753NIAID NIH HHS R21 AI083133NIAID NIH HHS R56 AI095088
6 · The paper itself

Abstract

Viruses evade immune detection partly through immune-associated mutations. Analyses of HIV sequences derived from infected individuals have identified numerous examples of HLA-associated mutations within or adjacent to T cell epitopes, but the potential impact of most mutations on epitope production and presentation remains unclear. The multistep breakdown of proteins into epitopes includes trimming of N-extended peptides into epitopes by aminopeptidases before loading onto MHC class I molecules. Definition of sequence signatures that modulate epitope production would lead to a better understanding of factors driving viral evolution and immune escape at the population level. In this study, we identified cytosolic aminopeptidases cleavage preferences in primary cells and its impact on HIV Ag degradation into epitopes in primary human cell extracts by mass spectrometry and on epitope presentation to CTL. We observed a hierarchy of preferred amino acid cleavage by cytosolic aminopeptidases. We demonstrated that flanking mutations producing more or less cleavable motifs can increase or decrease epitope production and presentation by up to 14-fold. We found that the efficiency of epitope production correlates with cleavability of flanking residues. These in vitro findings were supported by in vivo population-level analyses of clinically derived viral sequences from 1134 antiretroviral-naive HIV-infected individuals: HLA-associated mutations immune pressures drove the selection of residues that are less cleavable by aminopeptidases predominantly at N-flanking sites, leading to reduced epitope production and immune recognition. These results underscore an important and widespread role of Ag processing mutations in HIV immune escape and identify molecular mechanisms underlying impaired epitope presentation.

Indexed as

AminopeptidasesAntigen PresentationCell SeparationEpitopes, T-LymphocyteFlow CytometryHistocompatibility Antigens Class IHIV InfectionsHuman Immunodeficiency Virus ProteinsHumansImmune EvasionLymphocyte ActivationMutationAminopeptidasesEpitopes, T-LymphocyteHistocompatibility Antigens Class IHuman Immunodeficiency Virus Proteins

Identifiers

PMID22586036
PMCPMC3370117
OpenAlexW2133649920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.